1. A Retrospective Population Study of Congenital Heart Defects and Genetic Testing in Southern Arizona
- Author
-
Knight, Faith Elyse and Knight, Faith Elyse
- Abstract
Each year, nearly 40,000 children are born with a Congenital Heart Defect (CHD) in the United States, and 1 in 4 of them are born with a severe CHD requiring surgical intervention within their first year of life (Data and Statistics on Congenital Heart Defects, 2023). About 15% of CHDs are suspected to be due to genetic conditions (Data and Statistics on Congenital Heart Defects, 2023). We reviewed genetic testing trends among individuals with CHDs in Southern Arizona through Current Procedural Terminology (CPT) code analysis and retrospective chart review. We queried CPT codes for genetic testing in data collected by the Arizona Congenital Heart Defects Surveillance across Time And Regions (AZ CHD STAR), an initiative funded through the Centers for Disease Control and Prevention initiative. Out of 37,530 individuals with CHD in Southern Arizona born between 2000 and 2019, 478 (1.27%) underwent genetic testing. We completed medical record abstraction for 441 cases with genetic testing identified from clinical sources, and found genetic test results for 369 (82.9%). Of these 369 cases, 33.3% are individuals with Hispanic ethnicity and 48.8% are individuals with Non-Hispanic White ethnicity. There was a significant difference between the proportions of individuals with a Hispanic background in this study’s cohort compared to the general census data for Southern Arizona (33.3% vs. 43.5%; p value <.001) (QuickFacts: Arizona, 2023). Of all identified testing, individuals with severe CHDs accounted for 80% of total cases and chromosomal microarray was the testing methodology for 56% of all genetic tests. There was a significant difference between abnormal and normal results in severe and non-severe CHD cases for this cohort (chi-squared=11.706, p-value=<0.001), suggesting that abnormal results are more common in individuals with non-severe CHD presentations in this cohort. A majority of testing was performed on individuals with severe CHDs, suggesting that individuals wit
- Published
- 2024